Cargando…
Retraction Note to: RIPK3 interactions with MLKL and CaMKII mediate oligodendrocytes death in the developing brain
Autores principales: | Qu, Yi, Tang, Jun, Wang, Huiqing, Li, Shiping, Zhao, Fengyan, Zhang, Li, Lu, Q. Richard, Mu, Dezhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546882/ https://www.ncbi.nlm.nih.gov/pubmed/36207298 http://dx.doi.org/10.1038/s41419-022-05252-3 |
Ejemplares similares
-
RIPK3 interactions with MLKL and CaMKII mediate oligodendrocytes death in the developing brain
por: Qu, Yi, et al.
Publicado: (2017) -
MLKL and CaMKII Are Involved in RIPK3-Mediated Smooth Muscle Cell Necroptosis
por: Zhou, Ting, et al.
Publicado: (2021) -
Retracted: κ-Opioid Receptor Agonist Ameliorates Postoperative Neurocognitive Disorder by Activating the Ca(2+)/CaMKII/CREB Pathway
por: Healthcare Engineering, Journal of
Publicado: (2022) -
Retraction of ‘Nuclear CaMKII enhances histone H3 phosphorylation and remodels chromatin during cardiac hypertrophy’
Publicado: (2023) -
RIPK3-Mediated Necroptosis in Diabetic Cardiomyopathy Requires CaMKII Activation
por: Chen, Yun, et al.
Publicado: (2021)